QT interval and antidepressant use: a cross sectional study of electronic health records
about
'Big data' in mental health research: current status and emerging possibilitiesBig data: the next frontier for innovation in therapeutics and healthcareChanges in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trialCo-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric PatientsToward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sourcesA multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesVentricular dysrhythmias associated with poisoning and drug overdose: a 10-year review of statewide poison control center data from California.Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions.Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study.Adding smartphone-based cognitive-behavior therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial.Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSESelective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reportsElectrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline.Evaluation of matched control algorithms in EHR-based phenotyping studies: a case study of inflammatory bowel disease comorbiditiesPsychiatric treatment considerations with direct acting antivirals in hepatitis CCardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy menShort Report About the Inpatient Health Services Standards in Electronic Health Records.Effects of Escitalopram on Autonomic Function in Posttraumatic Stress Disorder Among Veterans of Operations Enduring Freedom and Iraqi Freedom (OEF/OIF).The use of statins for the treatment of depression in patients with acute coronary syndrome.Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.QT prolongation and torsades de pointes with psychotropic agentsAntidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care databaseA systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link.Abandoning personalization to get to precision in the pharmacotherapy of depression.Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram.Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.The use of non-narcotic pain medication in pediatric gastroenterology.CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.Risk of QT/QTc prolongation among newer non-SSRI antidepressants.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Risk-benefit analysis of antidepressant drug treatment in the elderly.Childhood functional abdominal pain: mechanisms and management.Is the Chinese medicinal formula Guipi Decoction () effective as an adjunctive treatment for depression? A meta-analysis of randomized controlled trials.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Management of depression after myocardial infarction.
P2860
Q26741297-BF9A8AD8-F798-4ABC-AEDA-262E0CFAD8E9Q27027248-455A0850-F856-4E7F-8431-3A62F0B32200Q28539543-36E97A4D-913D-4AEC-B1F3-AD5C7D02BE25Q28552117-77C585CA-5AF3-4784-B890-2452CA668C06Q28597791-629BBF70-22ED-486E-80F7-0E555A9DBB36Q30657759-75B05EC3-FBC9-44C0-A40E-8B424E952853Q30883223-C89A9BCD-4CFB-45D0-B13F-D10CE6200363Q31034655-FD0335A8-3EB3-41E1-8F6A-B658F2546850Q33165968-1D77637B-F3CA-4C76-B315-00BA4ABF825EQ33444180-616D8F4B-2E82-4F61-B9D9-CF050A849D8EQ33447922-6831004B-66E2-44E6-865B-A3EEBAF8F1CBQ33610031-9225A172-DFD5-4D6B-B95E-3137AD26C0C7Q34016220-3907FA97-5062-4377-B1BF-1F6DFF2EEEEBQ34093866-5E137CCA-17B0-4798-9FD5-E4B4AF2F25F9Q34663931-69A572E7-D28C-45B8-B97D-9C0C8558F4FAQ34721628-FB7F452E-B70B-48DD-B9BE-A31930AD9EC1Q35178973-B4D6B815-726C-4460-808F-35CB360F0AAFQ35224278-61B3D5C2-41FB-4C71-B5E7-1245FCC662B0Q35771047-D29D2D39-40B1-4436-986C-AC98DD97E150Q35776730-D8F2F9D4-A7ED-4CA1-9223-B647CE4CA352Q36043374-125B9BBA-FE3F-46A0-84FC-2B9C38E3AFD8Q36101440-269DA9F0-0C32-4BF5-8429-3B4677E555C0Q36125470-350AB7BF-1317-49CB-B5AD-9F5CE1A6A5EDQ36216816-9ACB394B-EE25-4A6F-89BE-5CB8C8A631E0Q36706808-2634C7C0-0401-4C36-A064-08D33C401441Q36719034-12D3B07B-CBCE-41F0-9D98-2215CB76D73BQ36848629-87DF3862-A303-4DC1-8E22-CA64E3AA99D7Q37274682-C6B253F3-F3FB-4090-B09A-C720D8B86FE1Q38153098-71244F58-ECF1-45BE-BB29-B0028EE58D95Q38197159-E32095C6-A733-4F33-BC6F-684B7DDFF95BQ38221358-9423D2FE-FEC2-4F7D-94AF-BAAA15934FFFQ38239777-ADBE8DF3-ACB3-474A-8D24-881CEBFF876DQ38244346-813A4F68-ACF0-408A-8FC3-53CB4E256E6FQ38247487-9A7FCC2A-4DFC-48EF-84AA-65CB958273BAQ38284625-0667C06E-AF7C-40BC-B708-E9C26DD3A2C4Q38286201-870AA017-B680-429D-91AA-A4235E1CDC96Q38349884-C11E65C7-44DE-48FD-9048-EFAB3A16D4B1Q38386096-2ACEF460-DFD9-4AEF-8CBC-1E71EC2DC07DQ38476909-6C350352-695E-464F-A632-E1FB1B0B7D97Q38567458-3A90C6AE-B8F9-464B-8004-77087AAA84C8
P2860
QT interval and antidepressant use: a cross sectional study of electronic health records
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
QT interval and antidepressant use: a cross sectional study of electronic health records
@ast
QT interval and antidepressant use: a cross sectional study of electronic health records
@en
QT interval and antidepressant use: a cross sectional study of electronic health records
@nl
type
label
QT interval and antidepressant use: a cross sectional study of electronic health records
@ast
QT interval and antidepressant use: a cross sectional study of electronic health records
@en
QT interval and antidepressant use: a cross sectional study of electronic health records
@nl
prefLabel
QT interval and antidepressant use: a cross sectional study of electronic health records
@ast
QT interval and antidepressant use: a cross sectional study of electronic health records
@en
QT interval and antidepressant use: a cross sectional study of electronic health records
@nl
P2093
P2860
P3181
P356
P1433
P1476
QT interval and antidepressant use: a cross sectional study of electronic health records
@en
P2093
Caitlin C Clements
Dan V Iosifescu
Jane L Erb
Jeffrey B Weilburg
Jordan W Smoller
Roy H Perlis
Shawn N Murphy
Susanne E Churchill
Victor M Castro
Vivian S Gainer
P2860
P3181
P356
10.1136/BMJ.F288
P407
P433
P577
2013-01-01T00:00:00Z